Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oral bioavailable ITRI-148 degrades androgen receptor variants and overcomes antiandrogen resistance in advanced prostate cancer. | Neoplasia | 2026 | 41237749 | PubTator, text mining | PubMed |
| Mapping the global landscape of molecular glues in drug discovery: a bibliometric analysis from 2010 to 2024. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 41108358 | PubTator, text mining | PubMed |
| Diagnostic sequencing identifies high-risk markers and mechanisms of resistance to guide immunotherapy selection. | Blood Adv | 2026 | 41092482 | PubTator, text mining | PubMed |
| A double-edged sword of neo-substrate degradation in PROTACs. | Eur J Med Chem | 2026 | 41072267 | PubTator, text mining | PubMed |
| Cereblon upregulation overcomes thalidomide resistance in multiple myeloma through mitochondrial functional reprogramming. | BMB Rep | 2026 | 40916643 | PubTator, text mining | PubMed |
| MolGlueDB: an online database of molecular glues. | Nucleic Acids Res | 2026 | 40842115 | PubTator, text mining | PubMed |
| Targeted Protein Degradation in Lung Cancer: The Emerging Role of PROTAC Technology and E3 Ligases. | Curr Med Chem | 2026 | 40671234 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of RIPK1-targeting PROTACs. | Mol Divers | 2026 | 40126738 | PubTator, text mining | PubMed |
| The Crystallography of Enzymes: A Retrospective and Beyond. | Crystals (Basel) | 2025 | 42416333 | PubTator, text mining | PubMed |
| Towards precision medicine for systemic lupus erythematosus and neuropsychiatric manifestations. | Expert Rev Precis Med Drug Dev | 2025 | 42281945 | PubTator, text mining | PubMed |
| An Update on Clinically Advanced PROTAC Degraders and Their Synthesis. | Molecules | 2025 | 41515330 | PubTator, text mining | PubMed |
| Tuning the open-close equilibrium of Cereblon with small molecules influences protein degradation. | bioRxiv | 2025 | 41497597 | PubTator, text mining | PubMed |
| Advancing PROTAC Discovery Through Artificial Intelligence: Opportunities, Challenges, and Future Directions. | Pharmaceuticals (Basel) | 2025 | 41471282 | PubTator, text mining | PubMed |
| CC-90009, a Cereblon E3 Ligase Modulator, Exhibits Antiviral Efficacy Against JEV In Vitro and In Vivo via Targeted Degradation of GSPT1 and Viral NS5 Protein. | Pharmaceutics | 2025 | 41471039 | PubTator, text mining | PubMed |
| The covalent docking software landscape: features and applications in drug design. | Brief Bioinform | 2025 | 41470049 | PubTator, text mining | PubMed |
| Clues for glues: from serendipity to nature's blueprints in degrader discovery. | Essays Biochem | 2025 | 41452132 | PubTator, text mining | PubMed |
| ER degradation for ER+/HER2- advanced or metastatic breast cancer: a phase 1 trial. | Nat Commun | 2025 | 41407710 | PubTator, text mining | PubMed |
| Leveraging Targeted Protein Degradation for G Protein-Coupled Receptors: The Development of CCR2 Molecular Degraders. | J Med Chem | 2025 | 41381043 | PubTator, text mining | PubMed |
| Conformational Dynamics in the Cell Membrane Interactions of Bispecific Targeted Degrader Therapeutics. | J Med Chem | 2025 | 41370364 | PubTator, text mining | PubMed |
| Context Matters: E3 Ligase-Ligand Pairing Strategies for Optimized PROTAC Performance. | Protein Cell | 2025 | 41369129 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=9